Skip to main navigation
Adamis
  • Contact Us
Select Page
  • About
    • Overview
    • Management
    • Board of Directors
  • Customized Medications
  • Products
  • Pipeline
    • Specialty Pharmaceuticals
    • APC – 1000
    • APC – 4000
    • APC – 6000
    • APC – 8000
  • Investors

    Investor Relations

    • Investors
    • Overview
    • News Releases
    • Stock Information
    • SEC Filings
    • Events and Presentations
    • Email Alerts
  • Careers
    • Partnerships
  • Contact Us

SEC Filing Details

Investor Relations

  • Investors
  • Overview
  • News Releases
  • Stock Information
  • SEC Filings
  • Events and Presentations
  • Email Alerts

Tools

  • Print Page

SEC Filing Details

Document Details

Form
SC 13G/A
Filing Date
Feb 16, 2021
Document Date
Feb 16, 2021
Form Description
An amendment to the SC 13G filing
Filing Group
Other
Company
Adamis Pharmaceuticals Corporation
Issuer
ADAMIS PHARMACEUTICALS CORP

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS
Adamis
  • About

  • Management
  • Board of Directors
Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) is a specialty biopharmaceutical company focused on developing and commercializing pharmaceutical products in the therapeutic areas of respiratory disease and allergy.
  • Customized Medications

  • Products

  • Pipeline

  • Specialty Pharmaceuticals
    • APC – 6000
    • APC – 8000
  • Metered Dose Inhalers
    • APC – 1000
  • Dry Powder Inhaler Platform
    • APC – 4000
  • Partnerships

Investor Relations

  • Investors
  • Overview
  • News Releases
  • Stock Information
  • SEC Filings
  • Events and Presentations
  • Email Alerts
  • Careers
  • Partnerships
  • Contact Us

858.997.2400
  • Privacy Statement
  • Terms of Use

2021 Copyright Adamis Pharmaceuticals Corporation